Lei Wang

31PUBLICATIONS
14CO-AUTHORS
Clinical pharmacology and therapeuticsPharmacogenomicsProteins and peptidesHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 12, 2026
Modulating phosphorylation by proximity-inducing strategy: an update.

|Jul 11, 2026
Discovery of DDO-4279 as a PP5 degrader for the treatment of obesity.

|Apr 15, 2026
Repurposing Ilaprazole as a PP5 TPR Domain Binder with Modulatory Effects on MAPK Signaling.

Yanyi He, Jinying Gu, Liwen Hua

|Jan 09, 2026
Discovery of (3R,4R)-15: An Advanced Factor B Inhibitor Entering Phase 3 for Complement-Mediated Diseases.

Changyou Ma, Jincai Su, Jiang Liu

|Nov 30, 2025
Targeting Cell division cycle 37: A Promising Novel Therapeutic Strategy.

Lixiao Zhang, Yuting Xin, Qidong You

|Sep 26, 2025
HSP90 Mediates Targeted Degradation of Nonclient Protein PARP1 for Breast Cancer Treatment.

Wei Liu, Jianfeng Liu, Huangliang Shu

Pageof 6

Frequent Collaborators

26 joint publications

Qidong You

5 joint publications

Qiuyue Zhang

4 joint publications

Xiaoli Xu

3 joint publications

Ruoning Wang